Plant Breeding and CRISPR Plants Market: By Type (Conventional Method, Biotechnological Method and Genetic Engineering), By Trait (Herbicide Tolerance, Disease Resistance, Yield Improvement, Temperature Tolerance, Grain Size Improvement, Stress Tolerance, Drought Resistance and Others), By Application (Cereals & Grains, Oilseed & Pulses, Fruits & Vegetables, Cash crops, Turf & Ornamental, Herbs & Microgreens, Medicinal Crops and Others), and Geography

Plant Breeding and CRISPR Plants Market size was valued at USD 12.8 billion in 2023 and is projected to grow at 12.4% CAGR over the forecast years to reach USD 29 billion by 2030. The Plant breeding and CRISPR plants market is experiencing significant growth, driven by several factors such as the rising global population, increasing demand for sustainable agriculture, and climate change. The global population is expected to reach 9.7 billion by 2050, which will put a strain on food production. Plant breeding and CRISPR can help to develop crops with higher yields, which can help to meet the growing demand for food. Consumers are becoming more interested in sustainable agriculture practices. Plant breeding and CRISPR can be used to develop crops that are more resistant to pests and diseases, which can help reduce the need for pesticides. Climate change is expected to hurt crop yields, where plant breeding and CRISPR can be used to develop crops that are more tolerant of drought, heat, and other stresses. Despite the growing market, the constraints factors will hinder market growth such as regulatory hurdles, public perception, and cost. The new applications of CRISPR, development of gene editing techniques, and increased investment are the opportunities that are shaping the future of the Plant breeding and CRISPR plants market. Convergence of plant breeding and CRISPR, focus on nutrition, and development of gene drives are the trends in recent years.

Plant Breeding and CRISPR Plants Market Key Players:

• In March 2023, Corteva Agriscience introduced an innovative gene-editing technology aimed at enhancing disease resistance in elite corn hybrids. This breakthrough concept combines existing disease-resistant traits within the corn genome, strategically positioning them to minimize production stress and bolster disease tolerance.
• In August 2022, Bayer expanded its investment by acquiring a controlling stake in CoverCress Inc., a sustainable low-carbon oilseed producer. This move aligns with Bayer’s sustainability goals and has the potential to reduce agricultural carbon emissions and dependence on nitrogen fertilizers. By leveraging the expertise of existing investors (including Bunge and Chevron/farmers), Bayer aims to create new revenue streams through the commercialization of oilseeds for renewable fuels and animal feed. Overall, this strategic investment contributes to the growth of Bayer’s operations.